SCHEMBL6771123

SCHEMBL6771123

CN(C)CCCNC(=O)C=Cc1cc2ncnc(NC(=O)Nc3c(Cl)cccc3Cl)c2s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 10/20 0.45
ERBB2 P04626 3/20 0.45
LCK P06239 3/20 0.44
KDM4E B2RXH2 2/20 0.37
HPGD P15428 2/20 0.37
ALDH1A1 P00352 1/20 0.37
AURKA O14965 1/20 0.37
NTRK1 P04629 1/20 0.37
CSF1R P07333 1/20 0.37
FLT3 P36888 1/20 0.37
NTRK3 Q16288 1/20 0.37
NTRK2 Q16620 1/20 0.37
AURKB Q96GD4 1/20 0.37
RAD52 P43351 1/20 0.37
CXCL8 P10145 1/20 0.36
ABL1 P00519 1/20 0.36
PDGFRB P09619 1/20 0.36
KIT P10721 1/20 0.36
FGFR1 P11362 1/20 0.36
SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6771114 1.00 EGFR (0.45) EGFRERBB2LCKKDM4EHPGD
SCHEMBL6781423 0.83 EGFR (0.43) EGFRERBB2AURKANTRK1
SCHEMBL6781420 0.83 EGFR (0.43) EGFRERBB2AURKANTRK1
SCHEMBL4419732 0.81 EGFR (0.38) EGFRFGFR1
SCHEMBL4419740 0.81 EGFR (0.38) EGFRFGFR1
Hydrochloric Acid SCHEMBL4432013 0.80 EGFR (0.37) EGFRAURKAFGFR1
Hydrochloric Acid SCHEMBL4432011 0.80 EGFR (0.37) EGFRAURKAFGFR1
SCHEMBL4429439 0.66 AURKA (0.51) EGFRAURKANTRK1CSF1RNTRK3
SCHEMBL4201064 0.63 EGFR (0.72) EGFRERBB2AURKB
SCHEMBL7221059 0.63 EGFR (0.62) EGFRERBB2KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6806274-B1 IMMUNOREGULATION OR IMMUNOSUPPRESSIVE AGENTS; TYROSINE KINASE INHIBITORS; PREVENTING ORGAN TRANSPLANT REJECTION; AUTOIMMUNE CONDITIONS; REDUCED SIDE EFFECTS ASTRAZENECA UK LIMITED (GB) 2004-10-19 US disclosed